RT Journal Article
T1 Skin lesions in children during the first wave of the SARS-CoV-2 pandemic.
T2 Lesiones cutáneas en niños durante la primera ola de la pandemia por SARS-CoV-2.
A1 Carazo Gallego, Begoña
A1 Martín Pedraz, Laura
A1 Galindo Zavala, Rocío
A1 Rivera Cuello, Mercedes
A1 Mediavilla Gradolph, Concepción
A1 Núñez Cuadros, Esmeralda
K1 COVID-19
K1 Chilblains
K1 Exantema
K1 Exanthema
K1 Manifestaciones cutáneas
K1 Perniosis
K1 SARS-CoV-2
K1 Skin manifestations
AB Cutaneous manifestations have been included in COVID-19 patients' clinical spectrum. Our objective was to determine the association between skin lesions in children and SARS-CoV-2 infection, analyzing others possible infectious/autoimmune etiologies. Observational, multicenter, cross-sectional study, about children with skin manifestations from April to May 2020. The diagnosis of SARS-CoV-2 was performed by PCR in nasopharyngeal exudate and/or presence of antibodies by serology. Sixty-two children were included, 9 (14.5%) presented positive antibodies to SARS-CoV-2, with no positive PCR to SARS-Cov-2 in those patients in whom it was made. Patients with positive serology to SARS-CoV-2 presented chilblains and/or vesicular-bullous skin lesions more frequently (66.7% vs. 24.5%, p=0.019). Generalized, urticarial and maculopapular rash was more common in patients with negative antibodies (37.7 vs. 0%, p=0.047), others pathogens were isolated in 41.5% of these patients. There were no significant differences in the positivity for autoantibodies between both groups. In our study, the presence of chilblains-like and/or vesicular lesions were significantly related to SARS-CoV-2 previous contact.
YR 2021
FD 2021-05-04
LK http://hdl.handle.net/10668/17812
UL http://hdl.handle.net/10668/17812
LA en
LA es
DS RISalud
RD Apr 5, 2025